{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:31:26Z","timestamp":1791070286461,"version":"4.1.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1093\/neuonc\/nou020","type":"journal-article","created":{"date-parts":[[2014,2,20]],"date-time":"2014-02-20T22:05:40Z","timestamp":1392933940000},"page":"1196-1209","source":"Crossref","is-referenced-by-count":29,"title":["Proteomic screening identifies a YAP-driven signaling network linked to tumor cell proliferation in human schwannomas"],"prefix":"10.1093","volume":"16","author":[{"given":"Aliz\u00e9e","family":"Boin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Couvelard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Couderc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Filipescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Kalamarides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Bedossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne","family":"De Koning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Danelsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Hup\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Louvard,","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Lallemand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,2,20]]},"reference":[{"issue":"9679","key":"key\n\t\t\t\t20170511102228_NOU020C1","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/S0140-6736(09)60259-2","article-title":"Neurofibromatosis type 2","volume":"373","author":"Asthagiri","year":"2009","journal-title":"Lancet"},{"issue":"6429","key":"key\n\t\t\t\t20170511102228_NOU020C2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/363515a0","article-title":"Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2","volume":"363","author":"Rouleau","year":"1993","journal-title":"Nature"},{"issue":"2","key":"key\n\t\t\t\t20170511102228_NOU020C3","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1158\/0008-5472.CAN-06-1608","article-title":"Merlin\/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac","volume":"67","author":"Morrison","year":"2007","journal-title":"Cancer Res"},{"issue":"1","key":"key\n\t\t\t\t20170511102228_NOU020C4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1534-5807(01)00009-0","article-title":"The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling","volume":"1","author":"Shaw","year":"2001","journal-title":"Dev Cell"},{"issue":"5","key":"key\n\t\t\t\t20170511102228_NOU020C5","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1083\/jcb.200703010","article-title":"Contact-dependent inhibition of EGFR signaling by Nf2\/Merlin","volume":"177","author":"Curto","year":"2007","journal-title":"J Cell Biol"},{"issue":"7","key":"key\n\t\t\t\t20170511102228_NOU020C6","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.cub.2006.02.063","article-title":"The tumor suppressors Merlin and Expanded function cooperatively to modulate receptor endocytosis and signaling","volume":"16","author":"Maitra","year":"2006","journal-title":"Curr Biol"},{"issue":"9","key":"key\n\t\t\t\t20170511102228_NOU020C7","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1101\/gad.1054603","article-title":"NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions","volume":"17","author":"Lallemand","year":"2003","journal-title":"Genes Dev"},{"issue":"4","key":"key\n\t\t\t\t20170511102228_NOU020C8","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.cell.2010.01.029","article-title":"Merlin\/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus","volume":"140","author":"Li","year":"2010","journal-title":"Cell"},{"issue":"1","key":"key\n\t\t\t\t20170511102228_NOU020C9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ncb1339","article-title":"The tumour-suppressor genes NF2\/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis","volume":"8","author":"Hamaratoglu","year":"2006","journal-title":"Nat Cell Biol"},{"issue":"2","key":"key\n\t\t\t\t20170511102228_NOU020C10","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.devcel.2009.12.012","article-title":"Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded","volume":"18","author":"Yu","year":"2010","journal-title":"Dev Cell"},{"issue":"1","key":"key\n\t\t\t\t20170511102228_NOU020C11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.devcel.2010.06.015","article-title":"The Merlin\/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals","volume":"19","author":"Zhang","year":"2010","journal-title":"Dev Cell"},{"issue":"21","key":"key\n\t\t\t\t20170511102228_NOU020C12","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1101\/gad.1602907","article-title":"Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control","volume":"21","author":"Zhao","year":"2007","journal-title":"Genes Dev"},{"issue":"3","key":"key\n\t\t\t\t20170511102228_NOU020C13","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1158\/0008-5472.CAN-08-2997","article-title":"Both TEAD-binding and WW domains are required for the growth stimulation and oncogenic transformation activity of yes-associated protein","volume":"69","author":"Zhao","year":"2009","journal-title":"Cancer Res"},{"issue":"7","key":"key\n\t\t\t\t20170511102228_NOU020C14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrneurol.2011.82","article-title":"Emerging therapeutic targets in schwannomas and other merlin-deficient tumors","volume":"7","author":"Ammoun","year":"2011","journal-title":"Nat Rev Neurol"},{"issue":"11","key":"key\n\t\t\t\t20170511102228_NOU020C15","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/hmg\/ddg146","article-title":"Upregulation of the Rac1\/JNK signaling pathway in primary human schwannoma cells","volume":"12","author":"Kaempchen","year":"2003","journal-title":"Hum Mol Genet"},{"issue":"3","key":"key\n\t\t\t\t20170511102228_NOU020C16","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/onc.2012.587","article-title":"Axl\/Gas6\/NF\u03baB signalling in schwannoma pathological proliferation, adhesion and survival","volume":"33","author":"Ammoun","year":"2013","journal-title":"Oncogene"},{"issue":"6","key":"key\n\t\t\t\t20170511102228_NOU020C17","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1365-2559.2009.03440.x","article-title":"Activation of ERK, AKT and JNK signalling pathways in human schwannomas in situ","volume":"55","author":"Hilton","year":"2009","journal-title":"Histopathology"},{"issue":"2","key":"key\n\t\t\t\t20170511102228_NOU020C18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00129492-200403000-00013","article-title":"Expression of neuregulin and activation of erbB receptors in vestibular schwannomas: possible autocrine loop stimulation","volume":"25","author":"Hansen","year":"2004","journal-title":"Otol Neurotol"},{"issue":"4","key":"key\n\t\t\t\t20170511102228_NOU020C19","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1056\/NEJMoa0902579","article-title":"Hearing improvement after bevacizumab in patients with neurofibromatosis type 2","volume":"361","author":"Plotkin","year":"2009","journal-title":"N Engl J Med"},{"issue":"29","key":"key\n\t\t\t\t20170511102228_NOU020C20","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1038\/onc.2012.378","article-title":"Profiling phospho-signaling networks in breast cancer using reverse-phase protein arrays","volume":"32","author":"Gujral","year":"2012","journal-title":"Oncogene"},{"issue":"25","key":"key\n\t\t\t\t20170511102228_NOU020C21","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1093\/hmg\/11.25.3179","article-title":"Neurofibromatosis 2 (NF2) tumor suppressor schwannomin and its interacting protein HRS regulate STAT signaling","volume":"11","author":"Scoles","year":"2002","journal-title":"Hum Mol Genet"},{"issue":"15","key":"key\n\t\t\t\t20170511102228_NOU020C22","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1128\/MCB.01581-08","article-title":"NF2\/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth","volume":"29","author":"James","year":"2009","journal-title":"Mol Cell Biol"},{"issue":"17","key":"key\n\t\t\t\t20170511102228_NOU020C23","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1038\/onc.2010.20","article-title":"NF2-deficient cells depend on the Rac1-canonical Wnt signaling pathway to promote the loss of contact inhibition of proliferation","volume":"29","author":"Bosco","year":"2010","journal-title":"Oncogene"},{"issue":"9","key":"key\n\t\t\t\t20170511102228_NOU020C24","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1074\/jbc.M709037200","article-title":"Tumor suppressor LATS1 is a negative regulator of oncogene YAP","volume":"283","author":"Hao","year":"2008","journal-title":"J Biol Chem"},{"issue":"10","key":"key\n\t\t\t\t20170511102228_NOU020C25","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/onc.2010.504","article-title":"AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma","volume":"30","author":"Xu","year":"2011","journal-title":"Oncogene"},{"issue":"14","key":"key\n\t\t\t\t20170511102228_NOU020C26","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1101\/gad.1664408","article-title":"TEAD mediates YAP-dependent gene induction and growth control","volume":"22","author":"Zhao","year":"2008","journal-title":"Genes Dev"},{"issue":"3","key":"key\n\t\t\t\t20170511102228_NOU020C27","first-page":"475","article-title":"Establishment and characterization of a schwannoma cell line from a patient with neurofibromatosis 2","volume":"20","author":"Hung","year":"2002","journal-title":"Int J Oncol"},{"issue":"1","key":"key\n\t\t\t\t20170511102228_NOU020C28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/mao.0b013e31815d4429","article-title":"ErbB and Nrg: potential molecular targets for vestibular schwannoma pharmacotherapy","volume":"29","author":"Doherty","year":"2008","journal-title":"Otol Neurotol"},{"issue":"8","key":"key\n\t\t\t\t20170511102228_NOU020C29","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/neuonc\/noq012","article-title":"ErbB\/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma","volume":"12","author":"Ammoun","year":"2010","journal-title":"Neuro Oncol"},{"issue":"6","key":"key\n\t\t\t\t20170511102228_NOU020C30","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/glia.20316","article-title":"Constitutive neuregulin-1\/ErbB signaling contributes to human vestibular schwannoma proliferation","volume":"53","author":"Hansen","year":"2006","journal-title":"Glia"},{"issue":"3","key":"key\n\t\t\t\t20170511102228_NOU020C31","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1677\/erc.0.0080151","article-title":"The ErbB receptor tyrosine family as signal integrators","volume":"8","author":"Hynes","year":"2001","journal-title":"Endocr Relat Cancer"},{"issue":"5827","key":"key\n\t\t\t\t20170511102228_NOU020C32","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.1141478","article-title":"MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling","volume":"316","author":"Engelman","year":"2007","journal-title":"Science"},{"issue":"2","key":"key\n\t\t\t\t20170511102228_NOU020C33","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3835(97)00469-2","article-title":"Comparative analysis of expression of hepatocyte growth factor and its receptor, c-met, in gliomas, meningiomas and schwannomas in humans","volume":"124","author":"Moriyama","year":"1998","journal-title":"Cancer Lett"},{"issue":"3","key":"key\n\t\t\t\t20170511102228_NOU020C34","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3892\/ijo.2013.1798","article-title":"Microarray analysis of gene expression in vestibular schwannomas reveals SPP1\/MET signaling pathway and androgen receptor deregulation","volume":"42","author":"Torres-Martin","year":"2013","journal-title":"Int J Oncol"},{"issue":"12","key":"key\n\t\t\t\t20170511102228_NOU020C35","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.jocn.2007.05.009","article-title":"Expression of ErbB-1 and 2 in vestibular schwannomas","volume":"14","author":"Wickremesekera","year":"2007","journal-title":"J Clin Neurosci"},{"issue":"7","key":"key\n\t\t\t\t20170511102228_NOU020C36","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1097\/MAO.0b013e3181eb328a","article-title":"Erlotinib for progressive vestibular schwannoma in neurofibromatosis 2 patients","volume":"31","author":"Plotkin","year":"2010","journal-title":"Otol Neurotol"},{"issue":"9","key":"key\n\t\t\t\t20170511102228_NOU020C37","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/neuonc\/nos146","article-title":"Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas","volume":"14","author":"Karajannis","year":"2012","journal-title":"Neuro Oncol"},{"issue":"6","key":"key\n\t\t\t\t20170511102228_NOU020C38","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1097\/MAO.0b013e31825e73f5","article-title":"Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients","volume":"33","author":"Plotkin","year":"2012","journal-title":"Otol Neurotol"},{"issue":"10","key":"key\n\t\t\t\t20170511102228_NOU020C39","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1158\/1535-7163.MCT-11-0116","article-title":"Targeting Axl and Mer kinases in cancer","volume":"10","author":"Verma","year":"2011","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"key\n\t\t\t\t20170511102228_NOU020C40","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1523\/JNEUROSCI.16-06-02012.1996","article-title":"Identification of Gas6 as a growth factor for human Schwann cells","volume":"16","author":"Li","year":"1996","journal-title":"J Neurosci"},{"issue":"39","key":"key\n\t\t\t\t20170511102228_NOU020C41","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1038\/onc.2009.212","article-title":"Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis","volume":"28","author":"Li","year":"2009","journal-title":"Oncogene"},{"issue":"6","key":"key\n\t\t\t\t20170511102228_NOU020C42","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1158\/0008-5472.CAN-09-1977","article-title":"Complementary Actions of Inhibitors of Angiopoietin-2 and VEGF on Tumor Angiogenesis and Growth","volume":"70","author":"Hashizume","year":"2010","journal-title":"Cancer Res"},{"issue":"29","key":"key\n\t\t\t\t20170511102228_NOU020C43","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1038\/onc.2012.378","article-title":"Profiling phospho-signaling networks in breast cancer using reverse-phase protein arrays","volume":"32","author":"Gujral","year":"2012","journal-title":"Oncogene"},{"issue":"2","key":"key\n\t\t\t\t20170511102228_NOU020C44","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.canlet.2006.10.017","article-title":"STAT3 as a central mediator of neoplastic cellular transformation","volume":"251","author":"Frank","year":"2007","journal-title":"Cancer Lett"},{"issue":"8","key":"key\n\t\t\t\t20170511102228_NOU020C45","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1158\/1078-0432.CCR-09-2658","article-title":"Nuclear localization of signal transducer and activator of transcription 3 in head and neck squamous cell carcinoma is associated with a better prognosis","volume":"16","author":"Pectasides","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"1","key":"key\n\t\t\t\t20170511102228_NOU020C46","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1101\/gad.1843810","article-title":"A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF\u03b2-TRCP","volume":"24","author":"Zhao","year":"2010","journal-title":"Genes Dev"},{"issue":"35","key":"key\n\t\t\t\t20170511102228_NOU020C47","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1038\/onc.2012.431","article-title":"LKB1 tumor suppressor regulates AMP kinase\/mTOR-independent cell growth and proliferation via the phosphorylation of Yap","volume":"32","author":"Nguyen","year":"2012","journal-title":"Oncogene"},{"issue":"6","key":"key\n\t\t\t\t20170511102228_NOU020C48","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/onc.2008.427","article-title":"Merlin regulates transmembrane receptor accumulation and signaling at the plasma membrane in primary mouse Schwann cells and in human schwannomas","volume":"28","author":"Lallemand","year":"2009","journal-title":"Oncogene"},{"issue":"6","key":"key\n\t\t\t\t20170511102228_NOU020C49","doi-asserted-by":"crossref","first-page":"e38686","DOI":"10.1371\/journal.pone.0038686","article-title":"NormaCurve: a SuperCurve-based method that simultaneously quantifies and normalizes reverse phase protein array data","volume":"7","author":"Troncale","year":"2012","journal-title":"PLoS One"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/16\/9\/1196\/16856443\/nou020.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T16:44:30Z","timestamp":1565196270000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-lookup\/doi\/10.1093\/neuonc\/nou020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,20]]},"references-count":49,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,2,20]]},"published-print":{"date-parts":[[2014,9]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/nou020","relation":{},"ISSN":["1523-5866","1522-8517"],"issn-type":[{"value":"1523-5866","type":"electronic"},{"value":"1522-8517","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2,20]]}}}